Profiel
Mr. Oscar C.
Lin is an Analyst at Axial Capital Management LLC.
Prior to joining Axial Capital Management, Mr. Lin worked at Nycomed Canada Inc. and GlaxoSmithKline.
Mr. Lin received his BSc in Biochemistry from the University of British Columbia, his MBT degree in Biotechnology from the University of Toronto, and his MBA in Finance and Healthcare Management from the University of Pennsylvania-Wharton School.
Eerdere bekende functies van Oscar C. Lin
| Bedrijven | Functie | Einde |
|---|---|---|
Takeda Canada, Inc.
Takeda Canada, Inc. Pharmaceuticals: MajorHealth Technology Engages in the manufacture, sale, marketing, import and export of pharmaceutical products | Corporate Officer/Principal | 01-04-2010 |
Axial Capital Management LLC
Axial Capital Management LLC Investment ManagersFinance Axial Capital is a small-cap investor. They do not focus on a particular sector. The firm maintains a medium turnover rate. | Analyst-Equity | - |
Opleiding van Oscar C. Lin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Axial Capital Management LLC
Axial Capital Management LLC Investment ManagersFinance Axial Capital is a small-cap investor. They do not focus on a particular sector. The firm maintains a medium turnover rate. | Finance |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Canada, Inc.
Takeda Canada, Inc. Pharmaceuticals: MajorHealth Technology Engages in the manufacture, sale, marketing, import and export of pharmaceutical products | Health Technology |
















